Bank of America Corporation »

Aerovate Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $514k 23k 22.63
2023-09-30 $140k 10k 13.57
2023-06-30 $108k 6.3k 17.15
2023-03-31 $268k 13k 20.17
2022-12-31 $221k 7.6k 29.30
2022-06-30 $32k 2.0k 15.85
2021-12-31 $112k 9.5k 11.78